Publications

Export 17 results:
Sort by: Author Title [ Type (Desc)] Year
Filters: Author is Sethi, Tariq  [Clear All Filters]
Journal Article
Henderson NC, Collis EA, Mackinnon AC, Simpson KJ, Haslett C, Zent R, et al. CD98hc (SLC3A2) interaction with beta 1 integrins is required for transformation. J Biol Chem. 2004;279(52):54731-41. Abstract
Rintoul RC, Buttery RC, Mackinnon AC, Wong WS, Mosher D, Haslett C, et al. Cross-linking CD98 promotes integrin-like signaling and anchorage-independent growth. Molecular biology of the cell. 2002;13:2841-52. Abstract
Rintoul RC, Buttery RC, Mackinnon AC, Wong WS, Mosher D, Haslett C, et al. Cross-linking CD98 promotes integrin-like signaling and anchorage-independent growth. Mol Biol Cell. 2002;13(8):2841-52. Abstract
Henderson NC, Mackinnon AC, Farnworth SL, Kipari T, Haslett C, Iredale JP, et al. Galectin-3 expression and secretion links macrophages to the promotion of renal fibrosis. Am J Pathol. 2008;172(2):288-98. Abstract
Farnworth SL, Henderson NC, Mackinnon AC, Atkinson KM, Wilkinson T, Dhaliwal K, et al. Galectin-3 reduces the severity of pneumococcal pneumonia by augmenting neutrophil function. Am J Pathol. 2008;172(2):395-405. Abstract
Henderson NC, Mackinnon AC, Farnworth SL, Poirier F, Russo FP, Iredale JP, et al. Galectin-3 regulates myofibroblast activation and hepatic fibrosis. Proc Natl Acad Sci USA. 2006;103(13):5060-5. Abstract
Dumitriu IE, Dunbar DR, Howie SE, Sethi T, Gregory CD. Human dendritic cells produce TGF-beta 1 under the influence of lung carcinoma cells and prime the differentiation of CD4+CD25+Foxp3+ regulatory T cells. Journal of immunology (Baltimore, Md. : 1950). 2009;182:2795-807. Abstract
Hodkinson PS, Elliott PA, Lad Y, McHugh BJ, Mackinnon AC, Haslett C, et al. Mammalian NOTCH-1 activates beta1 integrins via the small GTPase R-Ras. J Biol Chem. 2007;282(39):28991-9001. Abstract
Mackinnon AC, Kopatz J, Sethi T. The molecular and cellular biology of lung cancer: identifying novel therapeutic strategies. Br Med Bull. 2010;95:47-61. Abstract
Mackinnon AC, Kopatz J, Sethi T. The molecular and cellular biology of lung cancer: identifying novel therapeutic strategies. Br Med Bull. 2010;95:47-61. Abstract
Lad Y, McHugh B, Hodkinson PS, Mackinnon AC, Haslett C, Ginsberg MH, et al. Phospholipase C epsilon suppresses integrin activation. J Biol Chem. 2006;281(40):29501-12. Abstract
Mackinnon AC, Farnworth SL, Hodkinson PS, Henderson NC, Atkinson KM, Leffler H, et al. Regulation of alternative macrophage activation by galectin-3. J Immunol. 2008;180(4):2650-8. Abstract
Mackinnon AC, Buckley A, Chilvers ER, Rossi AG, Haslett C, Sethi T. Sphingosine kinase: a point of convergence in the action of diverse neutrophil priming agents. Journal of immunology (Baltimore, Md. : 1950). 2002;169:6394-400. Abstract
Mackinnon AC, Buckley A, Chilvers ER, Rossi AG, Haslett C, Sethi T. Sphingosine kinase: a point of convergence in the action of diverse neutrophil priming agents. J Immunol. 2002;169(11):6394-400. Abstract
Hodkinson PS, Mackinnon A, Sethi T. Targeting growth factors in lung cancer. Chest. 2008;133(5):1209-16. Abstract
Mackinnon AC, Tufail-Hanif U, Wheatley M, Rossi AG, Haslett C, Seckl M, et al. Targeting V1A-vasopressin receptors with [Arg6, D-Trp7,9, NmePhe8]-substance P (6-11) identifies a strategy to develop novel anti-cancer therapies. Br J Pharmacol. 2009;156(1):36-47. Abstract
Mackinnon A, Sethi T. [D-Arg6, D-Trp7,9, NmePhe8]-substance P (6-11) activates JNK and induces apoptosis in small cell lung cancer cells via an oxidant-dependent mechanism. Methods Mol Med. 2003;74:299-307.